FDA Scientists Raise Peptide Concerns Ahead of Committee Meeting

FDA career scientists have determined there is insufficient evidence to support peptides under consideration for production by compounding, countering HHS Secretary Robert F. Kennedy Jr.'s efforts to expand access to these substances.